{"result": "(\"entity\"<|>ESPEN<|>ORGANIZATION<|>The European Society for Clinical Nutrition and Metabolism (ESPEN) is an organization that provides guidelines and recommendations for clinical nutrition and metabolism, particularly in relation to intestinal failure.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutritional support and management strategies discussed in the context of intestinal failure.)\n##\n(\"entity\"<|>BALLASTEROS POMAR<|>PERSON<|>Ballesteros Pomar is a medical doctor who has contributed to the literature on short bowel syndrome and its management.)\n##\n(\"entity\"<|>VIDAL CASARIEGO<|>PERSON<|>Vidal Casariego is a medical professional who has co-authored research on short bowel syndrome and nutritional management.)\n##\n(\"entity\"<|>KLEK<|>PERSON<|>Klek is a researcher involved in the management of acute intestinal failure and has contributed to clinical nutrition guidelines.)\n##\n(\"entity\"<|>FORBES<|>PERSON<|>Forbes is a researcher who has worked on the management of acute intestinal failure and contributed to clinical nutrition literature.)\n##\n(\"entity\"<|>GABE<|>PERSON<|>Gabe is a researcher who has contributed to the understanding and management of acute intestinal failure.)\n##\n(\"entity\"<|>HOLST<|>PERSON<|>Holst is a researcher involved in the study of clinical nutrition and management of intestinal failure.)\n##\n(\"entity\"<|>WANTEN<|>PERSON<|>Wanten is a researcher who has contributed to the field of clinical nutrition and the management of intestinal failure.)\n##\n(\"entity\"<|>IRTUN<|>PERSON<|>Irtun is a researcher who has worked on clinical nutrition and the management of intestinal failure.)\n##\n(\"relationship\"<|>ESPEN<|>NUTRICIÓN<|>ESPEN provides guidelines and recommendations for nutritional management in cases of intestinal failure<|>8)\n##\n(\"relationship\"<|>BALLASTEROS POMAR<|>ESPEN<|>Ballesteros Pomar has contributed to the research and guidelines published by ESPEN regarding intestinal failure<|>7)\n##\n(\"relationship\"<|>VIDAL CASARIEGO<|>ESPEN<|>Vidal Casariego has co-authored research that aligns with ESPEN's guidelines on intestinal failure<|>7)\n##\n(\"relationship\"<|>KLEK<|>ESPEN<|>Klek has contributed to ESPEN's position papers on the management of acute intestinal failure<|>7)\n##\n(\"relationship\"<|>FORBES<|>ESPEN<|>Forbes has worked on research that informs ESPEN's guidelines for managing acute intestinal failure<|>7)\n##\n(\"relationship\"<|>GABE<|>ESPEN<|>Gabe has contributed to the literature that supports ESPEN's recommendations on intestinal failure<|>7)\n##\n(\"relationship\"<|>HOLST<|>ESPEN<|>Holst has been involved in research that aligns with ESPEN's guidelines on clinical nutrition<|>7)\n##\n(\"relationship\"<|>WANTEN<|>ESPEN<|>Wanten has contributed to the research that informs ESPEN's guidelines on the management of intestinal failure<|>7)\n##\n(\"relationship\"<|>IRTUN<|>ESPEN<|>Irtun has worked on clinical nutrition research that supports ESPEN's recommendations<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: en los siguientes obje-\n               COMENTARIO                                                                                                                                     tivos:\n               Se define como fallo intestinal la reducción de la función intestinal por debajo de un umbral                                                  •  Control de la sepsis.\n               mínimo necesario para la adecuada absorción de macronutrientes, agua y/o electrolitos, de                                                      •  Optimización hidroelectrolítica, metabólica y nutricional.\n               modo que es necesaria su suplementación para garantizar una salud adecuada.                                                                    •  Valoración de la función intestinal.\n               El fallo intestinal se puede clasificar por criterios fisiopatológicos:                                                                        •  Cuidado de las heridas y/o fístulas.\n                                                                                                                                                              •  Movilización y fisioterapia.\n               •  intestino corto;                                                                                                                            •  Prevención de complicaciones como las infecciones asociadas a catéteres venosos, úl-\n               •  fístula intestinal;                                                                                                                            ceras por presión, etc.\n               •  alteraciones de la motilidad intestinal;\n               •  obstrucción intestinal;                                                                                                                     La resucitación con sueros y electrolitos debe ser una fase previa al inicio del soporte nutri-\n               •  Enfermedad extensa de la mucosa intestinal,                                                                                                 cional, y debe ser suficiente como para cubrir las pérdidas digestivas y para garantizar una\n                                                                                                                                                              diuresis de al menos 25 ml/kg/día. En las fases iniciales, habitualmente la nutrición paren-\n               o por criterios funcionales:                                                                                                                   teral supone el único método eficaz de mantener el estado nutricional. Las guías ESPEN re-\n               •  tipo I: una situación aguda, generalmente autolimitada (días);                                                                              comiendan, además, fomentar la alimentación oral (salvo que exista obstrucción intestinal\n               •  tipo II: una condición aguda que se prolonga unas semanas o meses, a menudo acompa-                                                         o que se considere que el ayuno pueda contribuir al cierre de una fístula), preferiblemente\n                  ñada de inestabilidad metabólica;                                                                                                           guiada por un dietista; recomiendan además valorar siempre la administración de nutrición\n               •  tipo III: una situación crónica, en pacientes metabólicamente estables, que requieren suple-                                                enteral para favorecer el trofismo intestinal.\n                  mentación intravenosa durante meses o años.                                                                                                 Respecto al uso de fármacos, tanto los inhibidores de la bomba de protones como los an-\n               En adultos, existe riesgo de desarrollar fallo intestinal si hay:                                                                              tagonistas de los receptores H2 pueden reducir la producción de jugos gástricos, que se ve\n               •  menos de 35 cm de intestino delgado con una anastomosis yeyunoileal con colon intac-                                                        aumentada por la hipersecreción de gastrina secundaria a resecciones de intestino delgado.\n                  to;                                                                                                                                         El sobrecrecimiento bacteriano es una potencial complicación que puede aparecer durante\n               •  un intestino delgado de menos de 60 cm con anastomosis yeyunocólica;                                                                        la evolución del fallo intestinal, rara vez en la fase aguda. Cuando se diagnostica, debe\n               •  un intestino delgado de menos de 115 cm con yeyunostomía final;                                                                             tratarse con antibioticoterapia, pero el tratamiento con antibióticos no se considera una\n               •  una ileostomía terminal con un elevado débito de agua y electrolitos,                                                                       medida inicial que deba emplearse sistemáticamente.\n               •  restricciones de la ingesta oral para disminuir las pérdidas digestivas o por otras causas.                                                 Referencias:\n                                                                                                                                                              • Ballesteros Pomar MD, Vidal Casariego A. Síndrome de intestino corto: definición, causas, adaptación intestinal y sobrecrecimiento\n               Referencias:                                                                                                                                     bacteriano. Nutr Hosp. 2007;22(Supl. 2):74-85.\n               • Pironi L, Arends J, Baxter J, Bozzetti F, Peláez RB, Cuerda C. Home Artificial Nutrition & Chronic Intestinal Failure; Acute Intestinal      • Klek S, Forbes A, Gabe S, Holst M, Wanten G, Irtun Ø, et al. Management of acute intestinal failure: A position paper from the\n                 Failure Special Interest Groups of ESPEN. ESPEN endorsed recommendations. Definition and classification of intestinal failure in               European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clin Nutr. 2016;35(6):1209-18.\n                 adults. Clin Nutr. 2015;34(2):171-80.                                                                                                        • Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al; Home Artificial Nutrition & Chronic Intestinal Failure Special\n                                                                                                                                                                Interest Group of ESPEN. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247-307.\n\n\n\n242                                                                                                                                                                                                                                                                                           243\n---\n                                                                                                                                                                                                                                              NUTRICIÓN                           4\n\n\n\n     51\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}